February 13, 2024 – B. Braun Medical Inc. (B. Braun) introduced the launch of its new heparin sodium 2,000 items in 0.9% sodium chloride injection, 1,000 mL (2 items/mL), the fifth product in its portfolio of heparin premixed baggage.

This new addition to the portfolio enhances the corporate's capacity to fulfill the various wants of healthcare amenities and their sufferers for these high-alert medicines. B. Braun's heparin portfolio is manufactured utilizing EXCEL^® IV Containers not fabricated from pure rubber latex, DEHP or PVC, prioritizing affected person and environmental security. As well as, the product is manufactured and distributed by B. Braun's facility in Irvine, CA.

Heparin sodium 2,000 items in 0.9% sodium chloride injection 1,000 mL (2 items/mL) is indicated as an anticoagulant to take care of catheter patency.

Be taught extra